Peptides Nepal

Posts › 4 medicines that started as animal venom: snake, lizard…

4 medicines that started as animal venom: snake, lizard, sea snail and rattlesnake peptides

4 medicines that started as animal venom. A snake, a lizard, a sea snail and a rattlesnake: how scientists turned their venom molecules into real, approved medicines. Swipe.
Pit viper to captopril. Animal: Brazilian lancehead snake (Bothrops jararaca). Found: 1965, a venom factor (later found to be peptides) that boosts bradykinin, a body signal that relaxes blood vessels. Medicine: captopril, the first ACE inhibitor, for high blood pressure. Approved: USA, 1981. Twist: captopril is not a peptide; scientists copied the venom peptide's active end into a small molecule.
Gila monster to exenatide. Animal: Gila monster lizard (Heloderma suspectum). Found: 1990, Dr John Eng found exendin-4, a 39-amino-acid peptide, in its venom. Medicine: exenatide, a lab-made version, for type 2 diabetes. Approved: USA, 2005. Exendin-4 works on the same receptor as GLP-1, a gut hormone the body makes after meals.
Cone snail to ziconotide. Animal: fish-hunting sea snail (Conus magus). Found: a 25-amino-acid conopeptide in its venom. Medicine: ziconotide, a lab-made copy, for severe long-term pain when other treatments fail. Approved: USA, 2004. It blocks calcium channels in nerve cells, which damps down pain signals.
Rattlesnake to eptifibatide. Animal: pygmy rattlesnake, USA. Found: a venom protein that stops blood platelets from sticking together. Medicine: eptifibatide, a small ring-shaped (cyclic) peptide used in hospitals for some heart attacks. Approved: USA, 1998. Target: the GP IIb/IIIa receptor on platelets.
Timeline: 40 years, 4 medicines. 1965 bradykinin-boosting factor found in lancehead snake venom. 1981 captopril approved. 1990 exendin-4 found in Gila monster venom. 1998 eptifibatide approved. 2004 ziconotide approved. 2005 exenatide approved. From first clue to pharmacy shelf: often decades.
Venom is not a medicine. No: raw venom is a mix of many toxins and can be deadly. Yes: scientists isolate one molecule, study it, often change it, then make it in a lab. Yes: each medicine passed years of clinical trials before approval. Lesson: nature gives the idea; testing makes it a medicine.
Nature's lab, tested by science. Save this for later. Full guide: link in bio. Education only. Not medical advice. @peptidesnepal

• Lancehead snake venom → captopril, the first ACE inhibitor (approved 1981)
• Gila monster venom → exenatide for type 2 diabetes (2005)
• Cone snail venom → ziconotide for severe long-term pain (2004)
• Pygmy rattlesnake venom → eptifibatide, used in hospitals for some heart attacks (1998)
• The lesson: venom itself is dangerous. Scientists take ONE molecule, study it, and test it for years.

📌 Save this for the next "nature cures everything" debate.
📤 Send this to the friend who loves wildlife documentaries.

Which one surprised you most: snake, lizard, snail or rattlesnake?

Follow @peptidesnepal for more info
Visit our website — link in bio for detailed info like this!

Education only — not medical advice.

Sources

Sources 📚
• Captopril: Ferreira SH. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol, 1965 (PubMed 14302350); StatPearls, ACE Inhibitors (NCBI Bookshelf NBK430896): first ACE inhibitor, approved 1981; Univ. of Bristol Molecule of the Month: Captopril.
• Exenatide: US National Institute on Aging, "Exendin-4: From lizard to laboratory… and beyond"; NLM MeSH: Exenatide (39-amino-acid exendin-4 from Gila monster venom).
• Ziconotide: US FDA PRIALT prescribing information (NDA 021060; first label 2004).
• Eptifibatide: US FDA INTEGRILIN label (NDA 20-718, 1998); StatPearls, Eptifibatide (NCBI Bookshelf NBK541066).

View this post on Instagram →